Vita Coco (COCO) CFO sells 4,000 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

Vita Coco Company, Inc.’s Chief Financial Officer, Corey Baker, reported open‑market sales of 4,000 shares of common stock. The trades occurred on March 13, 2026 and March 16, 2026, with 2,000 shares sold at $58.86 and 2,000 shares at $57.98 per share.

After these transactions, Baker directly holds 31,951 shares of Vita Coco common stock. He also holds several non‑qualified stock options, including awards over 9,205 shares at $16.91 expiring on March 10, 2033 and 13,481 shares at $24.35 expiring on May 10, 2033. The sales were made under a pre‑arranged Rule 10b5‑1 trading plan.

Insights

Equity compensation & insider-transactions analyst

CFO’s 4,000-share sale is small, pre-planned, and leaves sizable equity exposure.

The CFO, Corey Baker, executed two open‑market sales totaling 4,000 shares of Vita Coco common stock at prices of $58.86 and $57.98 per share on March 13, 2026 and March 16, 2026. Following these trades, he still directly owns 31,951 shares, indicating that only a modest portion of his equity stake was sold.

The filing notes the transactions were effected pursuant to a Rule 10b5‑1 trading plan, meaning they were pre‑scheduled rather than timed discretionarily. Baker also retains multiple non‑qualified stock options with exercise prices from $16.91 to $33.36 and expirations between 2033 and 2035, preserving long‑term upside exposure linked to the company’s performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAKER COREY

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		S(1)		2,000	D	$58.86	33,951	D
Common Stock	03/16/2026		S(1)		2,000	D	$57.98	31,951	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$16.91							(2)	03/10/2033	Common Stock	9,205		9,205	D
Non-Qualified Stock Option (Right to Buy)	$24.35							(3)	05/10/2033	Common Stock	13,481		13,481	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(4)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (Right to Buy)	$27.59							(3)	08/07/2033	Common Stock	11,547		11,547	D
Non-Qualified Stock Option (Right to Buy)	$33.36							(5)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option vests in four equal annual installments beginning on March 10, 2024.

3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.

4. The stock option vests in four equal annual installments beginning on March 4, 2025.

5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	/s/ Alison Klein, attorney-in-fact for Corey Baker	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Vita Coco (COCO) CFO Corey Baker report in this Form 4 filing?

Corey Baker reported selling 4,000 shares of Vita Coco common stock in two open-market transactions. He sold 2,000 shares at $58.86 on March 13, 2026, and 2,000 shares at $57.98 on March 16, 2026, under a Rule 10b5-1 trading plan.

How many Vita Coco shares does the CFO own after these insider sales?

After the reported sales, Vita Coco’s CFO Corey Baker directly owns 31,951 shares of common stock. This reflects his remaining equity stake following the 4,000 shares sold in March 2026, indicating he continues to hold a meaningful ownership position in the company.

Were Corey Baker’s Vita Coco share sales part of a Rule 10b5-1 plan?

Yes. The filing states that the sales of Vita Coco common stock were effected under a Rule 10b5-1 trading plan. Such plans are pre-arranged, allowing executives to systematically sell shares over time, which can reduce concerns about discretionary trade timing.

At what prices did Vita Coco’s CFO sell his COCO shares in March 2026?

Corey Baker sold 2,000 Vita Coco shares at $58.86 per share on March 13, 2026, and another 2,000 shares at $57.98 per share on March 16, 2026. Both transactions were open-market sales of common stock under a pre-planned trading arrangement.

What stock options does the Vita Coco CFO hold according to this Form 4?

The CFO holds several non-qualified stock options on Vita Coco common stock, including 9,205 underlying shares at a $16.91 exercise price expiring March 10, 2033, and 13,481 underlying shares at $24.35 expiring May 10, 2033, plus additional options with exercise prices up to $33.36 through 2035.

Do the reported insider sales significantly reduce the Vita Coco CFO’s equity exposure?

The sales reduce his holdings but leave a substantial position. After selling 4,000 shares, Corey Baker still directly owns 31,951 Vita Coco shares and holds multiple option grants extending to 2033–2035, so he remains meaningfully exposed to the company’s future stock performance.